Connect with us

corporations

Akanda Corporation acquires Holigen from Flowr for €26 million with an eye on adult use

Published

em

Listen to this article

Akanda Corporation, a UK-based company with operations in Africa, acquired the Portuguese company Holigen from Flowr Corporation for €26 million, thus achieving GMP certification in the European Union. With the indoor cultivation unit in Sintra, designed to produce more than two tons of medical cannabis per year, Akanda is also positioning itself for the adult use market, also acquiring the Aljustrel production unit, with about 40 hectares. This transaction guarantees Akanda a leading position in the cannabis sector in Europe, the Middle East and Africa (EMEA).

Akanda already owned a growing facility in Lesotho, one of the first African countries to legalize medical cannabis, and CanMart, an import and distribution company that supplies pharmacies and clinics in the UK. Cannareporter has tried to contact Akanda CEO Tej Virk, but to no avail so far.

The deal will add valuable cultivation, manufacturing and distribution assets to publicly traded Akanda (NASDAQ: AKAN) to “accelerate the seed-to-patient model and meet high demand in European medical cannabis markets, as well as position it in the adult use market as regulations evolve,” says Press release.

A Holigen, which owns the Portuguese subsidiary RPK Biopharma, was acquired in June 2019 by Flowr Corporation and obtained a license from Infarmed shortly afterwards, in July 2019, having been considered a PIN – Project of National Interest, by investing more than 40 million euros in Portugal.

In early 2022, Flowr announced that subsidiary Holigen had successfully completed the first medical cannabis crop with high THC content at the Sintra facilities, expecting to harvest approximately 300 kilos in the first quarter. Estimates point to an annual production of more than two tons of “cannabis premium“ in one of the few units with European certification of good manufacturing practices (GMP), in addition to more than 100 tons of cannabis grown outside, in Aljustrel.

Under the terms of the acquisition, Akanda will also benefit from the genetic library provided by Flowr, including its award-winning BC Pink Kush, BC Black Cherry and BC Strawnana, as well as some new exotic genetics that will be exported to Portugal from Canada. Initial trials underway for both medical cannabis genetics are indicating high levels of THC content, greater than 25%.

The European medical cannabis market continues to grow as other countries update their medical cannabis laws. Prohibition Partners estimates that the medical market generated approximately $382 million in 2022 and will reach $2,5 billion by 2026.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Health2 days ago

Cannabinoids reveal promising results in the treatment of Borderline Personality Disorder

An investigation carried out by Khiron LifeSciences and coordinated by Guillermo Moreno Sanz suggests that medicines based on...

International2 days ago

Juicy Fields case: 9 detained by Europol and Eurojustice. Scam exceeds 645 million euros

A joint investigation conducted by several European authorities, supported by Europol and Eurojust, culminated in the arrest of nine suspects...

International5 days ago

Regular cannabis users may require more anesthesia during medical procedures

Regular cannabis users may require more anesthesia during medical procedures to remain sedated compared to...

International6 days ago

The future of CBD in Japan: How legal reforms will shape the market

Late last year, Japan took a big step towards cannabis reform after approving...

National7 days ago

Portugal: GreenBe Pharma obtains EuGMP certification at Elvas facilities

GreenBe Pharma, a medical cannabis company located in Elvas, Portugal, has obtained EU-GMP certification under...

National2 weeks ago

Álvaro Covões, from Everything is New, buys Clever Leaves facilities in Alentejo for 1.4 million euros

Álvaro Covões, founder and CEO of the show promotion agency 'Everything is New', which organizes one of the biggest festivals in...

Events2 weeks ago

ICBC returns to Berlin on April 16th and 17th

It is one of the largest and most recognized B2B cannabis conferences in Europe and returns to Berlin in...

International2 weeks ago

The legalization of cannabis in Germany seen through the eyes of the hacker who created an essential map

A hacker from Koblenz, a city in the state of Rhineland-Palatinate, created a map with the places where, from...

National2 weeks ago

André Ventura says he wants to “Clean up all cannabis in Portugal”

André Ventura, the well-known leader of the far-right Portuguese political party Chega, has said he wants to “cleanse all cannabis from...

International2 weeks ago

USA: Kamala Harris says the current classification of cannabis is “absurd” and “manifestly unfair”

The Vice President of the United States of America (USA), Kamala Harris, last week defended the declassification of cannabis in the table...